Bixiye
January 2025 Bulletin Summary
Taariikhda uu dhaqangalayo Barnaamijka: Jan 02, 2025
Natiijooyinka Raadinta
Soo bandhiga 2641 - 2650 ee natiijooyinka 4296
Bixiye
QP1-25 Commercial Pharmacy Benefit Exclusion for Aucatzyl® and Rapiblyk™
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2025
Bixiye
QP3-25 Post-Payment Medical Necessity Review of Inpatient Admissions
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2025
Bixiye
QP2-25 MHCP Pharmacy Benefit Exclusion for Aucatzyl®, Axtle™, Boruzu®, Rapiblyk™ and Ziihera®
Taariikhda uu dhaqangalayo Barnaamijka: Jan 08, 2025
Faa'iidooyinka & Caymiska
Dukaamaysiga & Barashada
How to Read Your Explanation of Health Care Benefits (EOB) Statement
Bixiye
P19R2-18 Update: New Remittance Code OA-45/N801 for Purchased/Referred Care (PRC) - Eligible Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Bixiye
P54-16 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2016
Bixiye
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2017